POM Investment Strategies »

Revance Therapeutics shares owned by POM Investment Strategies

Quarter-by-quarter ownership of Revance Therapeutics shares owned by POM Investment Strategies from 13F filings

Historical chart of POM Investment Strategies investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by POM Investment Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by POM Investment Strategies

Quarter filed Position value Share count Share price at filing
2024-12-31 $7.9k 2.6k 3.04
2024-09-30 $13k 2.6k 5.19
2024-06-30 $6.6k 2.6k 2.57
2024-03-31 $13k 2.6k 4.92
2023-12-31 $23k 2.6k 8.79

More positions owned by POM Investment Strategies

Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Msci Emg Mkt Etf (EEM)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Ishares Tr Msci Usa Mmentm (MTUM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Europe Etf (IEV)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Tr Core Msci Eafe (IEFA)
Simplify Exchange Traded Fun Treasury Opt Inc (BUCK)
Simplify Exchange Traded Fun Enhanced Inm Etf (HIGH)
Simplify Exchange Traded Fun Managed Futures (CTA)
Simplify Exchange Traded Fun Volatility Prem (SVOL)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Simplify Exchange Traded Fun Barrier Income (SBAR)

View all positions for POM Investment Strategies